Search - tctmd.com

Displaying 461 - 480 of 8902

Sort: Relevancy | Date

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

February 19, 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

February 18, 2025

Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months

News Conference News

NOW PUBLISHED: Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months

Yael L. Maxwell

February 18, 2025

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

February 14, 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

February 14, 2025

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

Challenges of Long-Term Follow-Up with Sreek Vemulapalli and Roseann White

Podcast Heart Valve Matters

Challenges of Long-Term Follow-Up with Sreek Vemulapalli and Roseann White

February 14, 2025

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

Clinical Trial Options

Presentation THT 2025

Clinical Trial Options

Presenter: Navin Kapur

February 13, 2025

This Strategy Has Saved the Startup Medical Device Sector

Presentation THT 2025

This Strategy Has Saved the Startup Medical Device Sector

Presenter: William Abraham

February 13, 2025

Down-Stream Challenges: Reimbursement and Guidelines

Presentation THT 2025

Down-Stream Challenges: Reimbursement and Guidelines

Presenter: Philip Adamson

February 13, 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

February 12, 2025

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Presentation THT 2025

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Presenter: Jonathan Weinsaft

February 12, 2025

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Presentation THT 2025

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Presenter: Marat Fudim

February 12, 2025

AI Echo's Potential to Transform HF Management

Presentation THT 2025

AI Echo's Potential to Transform HF Management

Presenter: Carolyn Lam

February 12, 2025

HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment

Presentation THT 2025

HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment

Presenter: Jonathan Cunningham

February 12, 2025

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Presentation THT 2025

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Presenter: Akhil Narang

February 12, 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presentation THT 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presenter: Nir Uriel

February 12, 2025

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Presentation THT 2025

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Presenter: Mary Acosta

February 12, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.